Evonik has purchased Eli Lilly's Tippecanoe, IN, manufacturing facility to strengthen its API production capabilities in the US. Financial terms for the deal, which is expected to close by the end of the year, have not been disclosed. In addition, Evonik has entered into a nine-year API production deal with Lilly.
Reuters
Wednesday 14 October 2009
Evonik expands US API capabilities
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment